Osteoporosis is a devastating, age-related disorder which can be prevented. Epidemiological data on prevalence of osteoporosis implies that 80% of all cases occur in mature women, but the consequences of osteoporosis in males are often more severe. Osteoporotic fragility of bone remains poorly understood, but it is clear that poor nutrition may play a pivotal role in pathogenesis. Life-long calcium deficiency is well associated with the occurrence of osteoporosis in later life, but the value of calcium alone for the management or prevention of osteoporosis may have been overemphasized. Diagnostic techniques using standard imaging or laboratory testing have been superseded by bone density screening using dual X-ray absorptiometry. While calcium and hormonal supplementation have been shown to be variably effective in controlled clinical trials of individuals with reduced bone density, the popular use of these therapies has occurred at the expense of considering other safe bone-building nutrients, such as: isoflavones, isoflavone derivatives, micronutrient metals, vitamin D, vitamin K, antioxidants and B class vitamins that lower blood homocysteine levels. There is no nutritional “magic bullet” for osteoporosis management. The Antiporosis Plan to combat thin bones involves risk assessment, change from adverse to positive lifestyle, secondary prevention with bone density screening, education on injury prevention and an integrated management approach, involving selected bone-boosting nutrients and a bone-boosting diet that is somewhat restricted in animal protein. An osteoporotic bone fracture is often unheralded in the elderly and it is often a major milestone for the reduction of quality of life and premature mortality. While effective drug therapy exists for the reversal of bone density in osteoporosis, pharmaceuticals posses disadvantages and limitations in their use. The first-line approach has to be holistic in nature.

Spread the word. Share this post!

Leave A Reply